Download Center
DATE: 6th, 7th & 8th of March 2013
Email: reg@cold-gdp.com
Location is Brussels, Belgium
Spekers
Speakers
  • SPEAKER: Verena Brenner, Reseach Associate, Cold-Chain Management, Jacobs University

  • SPEAKER: Nathan De Valck, Cargo Account Manager - Cold Chain - Brussels Airport Company

  • SPEAKER: Andrea Gruber, Business and Standards, IATA

  • SPEAKER: Drs R.J. Bruinink, Healthcare Inspectorate The Netherlands, Senior GMP and GDP Inspector

  • SPEAKER: Jens Lamberth, Global Category, AstraZeneca

  • SPEAKER: Maurizio Caschera, Quality Assurance, Sanofi Pasture-MSD

  • SPEAKER: Ulrike Kreysa, GS1 Global Office, Vice-President Healthcare

  • SPEAKER: Debby Mattys, MSD Global Logistics Operations EMEA Director

  • SPEAKER: Patrick Pichler, GMP Inspector, The Austrian Health Agency, AGES

  • SPEAKER: Luc Huybreghts, SR. QA Consultant Pharma Services

  • SPEAKER: Edith Penxten, Director EMEA, BMS

  • SPEAKER: PD Dr. Judith Kreyenschmidt, Cold-Chain Management Group, ITW, Management Group of the University of Bonn – Universität Bonn

  • SPEAKER: Laurent Foetisch, Managing Director, Supply Chain Operations SA

  • SPEAKER: Frank Peeters, PhD, QP, Managing Director, Tobeas

Spekers
Attendees

    Sample List of Attendees 2012:

     • AFMPS Belgium Health Agency Head of Inspection GDP/GMP

    • German Health Agency Senior GDP/GMP Inspectorate

    • Statens Serum Institute Qualified Person Quality Assurance

    • Statens Serum Institute Shipping Manager

    • Boehringer Ingelheim Head of Supply & Quality Management

    • MSD-Ireland Validation Engineer

    • Merck Global Logistics - EMEA

    • Amgen Senior Transport Manager

    • Merck - France Logistic Manager - Shipping / Export / Internal flow

    • Almirall S.A. Corporate QA &Supplier Selection

    • Almirall S.A. Corporate QA & Manager Logistics

    • Janssen Pharmaceutica nv Senior Manager - Qualified Person QA

    • Janssen Pharmaceutica nv Head of Global Division - Qualified Person - QA

    • Baxter Director Transport EMEA

    • Sanofi Quality Assurance

    • Penske Cold Chain Specialist

    • BTGIL - (Vaccine company Israel) Head of Logistics

    • BTGIL - (Vaccine company Israel) Quality and Logistics

    • Bayer Healthcare Clinical Distribution

    • Cardio3 BioSciences S.A. Supply Chain Manager

    • Alcon Labs Supply Chain Manager

    • Baxter Supply Chain Director

    • Merck India Director of Distribution

    • UPS Senior Director of QA

    • Perrigo Pharmaceuticals Logistics Director

Spekers
Hot Topics
  • Good Distribution Practices
  • Risk mitigation and cost fail safe techniques
  • Process harmonisation
  • Cost and quality
  • Harmonisation or/and Standardisation
  • Transport and distribution
  • Ambient Products
  • IATA Standards
  • Role of external partners
  • Interpretation of the current GDP
  • Selecting vendors or logistics providers
  • EMA GDP drafting
  • Handling excursions
  • Mitigating potential risks
  • Cold Chain Optimisation
  • Passive and Active
  • USA v EU packaging
  • Thermal route qualification
  • Costs of validation
  • Security review
     

 

Spekers
Key Benefits

1. Correct interpretation of the Good Distribution Guidelines
2. Addressing fundamental points concerning transportation and logistics
3. Meet European GDP Inspectorate and PCCIG working draft group
4. A step by step approach to Ambient medicine supply chain
5. Assess novel and growing trends concerning Passive V Active
6. Best practice for Time and Temperature Controlled
7. Vendor selection and choice of technology
8. Risk assessments and mitigation involved in distribution
9. Address the question of cost effectiveness in relation to quality
10. Practical case studies shared from the field

Cold Supply Chain Conference 2013

2nd annual Brussels Cold Chain Event: CSS2013 is a premier discussion designed with direct contribution and aid practitioners. Colleagues and experts engaged in both strategic and daily activities concerning temperature controlled products within the life science industry. CSS2013 is intended for professionals from the field concerned with expanding their knowledge base, learning and bench marking from practical.The programme draws strength from addressing fundamentally difficult critical points through practical and new case studies.

CSS2013 addresses the current GDP Guidelines (Draft), Emerging Markets and new ideas in relation to costs, quality and standardization of processes. The case studies and topics are practical in nature and focused on current challenges and future trends. The symposium covers key drivers and inhibitors in relation to where the main focus will be within the next 12 to 18 months.


Master Workshops and Auxiliary Session

  • Open Panel Dialogue
    With EU GDP and Cold Chain Experts Are you interested to learn the correct interpretation of the GDP guidelines?
  • Master Workshop A
    End to End Temperature Controlled Chain Management - Associated Challenges and Risks Mitigation Headache – For full Workshop detail download the PDF from the Download Centre.
  • Master Workshop B
    Good Distribution Practices and the impact on Temperature Regulated and Temperature Controlled Medicine for Human Consumption – For full Workshop detail download the PDF from the Download Center
  • Round Table Dialogue
    Ambient Products
    Traceability and Clinical Products
    GDP
    Passive V Active
Cold Supply Chain Conference 2013 Day1

Day1

Contingency/back up plans if and so when delays occur. A criterion based approach toward cost vs quality.

Read More
Cold Supply Chain Conference 2013 Day2

Day2

Cold chain compliance and risk assessment. Developing a cold chain management for biological products

Read More
  •  

    Thank you the platform as promised was end user driven and I really appreciate that only two other competitors were accepted on site. We do not see the need to for any further marketing investment. I thank you again and will see again next year.

    - Mr MertensLeClercq, Wallonia, Belgium
  •  

    All in one approach! I certainly enjoyed the sessions – but the networking was exceptionally outstanding.

    - Dr Jurgen Becker, Darmstadt, Germany
  •  

    The symposium was refreshing to say the least, and while it is true that it is was end user driven I must admit to see a limited quality vendors was something I have not experienced before.

    - Mr A. Blanc – Montpelier, France
  •  

    joined this event to learn and benchmark from other pharma companies – but the support I received in meeting and hearing all the presentation was truthfully outstanding. This is a must attend event if you want to learn something new and unique.

    - Mrs A. Van De Lange, Netherlands
  •  

    We attend many conferences and must admit your current strategy of non-commercial approach must be the key to have so many end users attending. I can truthfully say we learned what the market and customers are looking for and we will reposition for next year.

    - Mr C. Atkins, Cambridge, United Kingdom
  •  

    “We are very pleased to be part of this event; I describe it as a fantastic opportunity to network with a list of who is who in the market.”

    - Senior GDP Manager, Germany

PharmaDialogue Testimonials

google+ email facebook twitter
Connect with us